Correction: Maranto et al. Prospects for Clinical Development of Stat5 Inhibitor IST5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In Vivo. Cancers 2020, 12, 3412
更正:Maranto 等人,《Stat5 抑制剂 IST5-002 的临床开发前景:在前列腺癌中具有高转录组特异性和体内低毒性》,Cancers 2020, 12, 3412
期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17060932
Maranto, Cristina; Udhane, Vindhya; Jia, Jing; Verma, Ranjit; Müller-Newen, Gerhard; LaViolette, Peter S; Pereckas, Michael; Sabharwal, Lavannya; Terhune, Scott; Pattabiraman, Nagarajan; Njar, Vincent C O; Imig, John D; Wang, Liang; Nevalainen, Marja T